Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

The requested reference [a224c8513430b85d99b2386aafa1256eb7701514] no longer exists in our database. It has been replaced by the current reference: [c1535005781cdfdbaafd8812bfea846ae3029229]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2000
The study will compare and evaluate the effects of long-term treatment of monotherapy with rosiglitazone, metformin and glyburide/glibenclamide on the improvement and maintenance of glycemic control in patients with recently diagnosed type 2 diabetes mellitus.
Epistemonikos ID: 490b2d796caa820f18b769c711755ce113524528
First added on: Dec 24, 2014